๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wuhan
Clinical trial register · China

Clinical Trials in Wuhan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology165 Tongji Hospital139 Huazhong University of Science and Technology45 Novartis Pharmaceuticals33 AbbVie31
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Wuhan

1343 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
A Clinical Study of Chinese Herbal Formula TJAOA103 in Treating Genitourinary Syndrome of Menopause
NCT07160127Genitourinary Syndrome of Menopause (GSM)
Tongji Hospital
Phase EARLY_PHASE1
113
Wuhan
2025-09-15
Recruiting
GC012F Injection in Refractory Idiopathic Inflammatory Myopathy
NCT07086404Idiopathic Inflammatory Myopathy (IIM)
Daishi Tian
Phase EARLY_PHASE1
12
Wuhan
2025-09-15
Recruiting
A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation
NCT07174908Non-Small Cell Lung Cancer
InxMed (Shanghai) Co., Ltd.
Phase 3
400
Beijing, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Gannan, Nanchang
2025-09-10
Recruiting
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
NCT06919965Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC
Phase 3
220
Beijing, Chengdu, Guangzhou, Nanjing, Ningbo, Tianjin, Wenzhou, Wuhan
2025-09-10
Recruiting
Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease
NCT06824103Graft vs. Host Disease, Chronic Graft vs. Host Disease, Corticosteroid-refractory Chronic Graft vs. Host Disease
Novartis Pharmaceuticals
Phase 4
50
Hefei, Guangzhou, Nanning, Guiyang, Shijiazhuang, Zhengzhou, Wuhan, Nanjing
2025-09-09
Recruiting
An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies
NCT07101705Multiple Myeloma (MM), Non-Hodgkin Lymphoma (NHL)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
40
Wuhan
2025-09-08
Recruiting
A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma
NCT07099430Advanced Melanoma
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2
200
Fuzhou, Guangzhou, Nanning, Wuhan, Nanjing, Changchun, Jinan, Shanghai
2025-09-05
Recruiting
cfDNA Methylation for Liver Cancer Recurrence Detection
NCT07466602Primary Liver Cancer
Wuhan Ammunition Life-tech Co., Ltd
Observational
500
Wuhan
2025-09-02
Not yet open
Multimodal Identification of Depressive Symptoms in the Elderly
NCT07112118Depression
Wuhan Mental Health Centre
Observational
2,000
Wuhan
2025-09-01
Recruiting
Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
NCT07301814Gastric Cancer, Pancreatic Cancer, Cholangiocarcinoma Cancer, Esophageal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
56
Wuhan
2025-09-01
Recruiting
Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases
NCT07090200Respiratory Diseases, Cardiovascular Diseases, Cerebrovascular Diseases
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
50,000
Wuhan
2025-09-01
Recruiting
KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT07260812Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL)
TCRx Therapeutics Co.Ltd
Phase 1
18
Wuhan
2025-09-01
Recruiting
A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT
NCT07606703Chronic Graft-Versus-Host Disease, Graft vs Host Disease
WeiShi
Phase 2
30
Wuhan
2025-09-01
Not yet open
Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
NCT06580223Multiple Myeloma, Venous Thromboembolism
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3
530
Wuhan
2025-09-01
Active, closed
High-frequency Repetitive Transcranial Magnetic Stimulation for Patients With Dysphagia After Extubation
NCT07381946Post-extubation Dysphagia
Wuhan University
Not applicable
60
Wuhan
2025-09-01
Recruiting
Angong Niuhuang Pills With Different Bovine Bezoar Formulation Sources in the Treatment of AIS
NCT06883110Acute Ischemic Stroke
Tongji Hospital
Not applicable
100
Wuhan
2025-09-01
Active, closed
Machine Learning-based Classification of Symptom Clusters and Online CBT
NCT06350201Depression and Anxiety Symptom
Wuhan Mental Health Centre
Not applicable
409
Wuhan
2025-09-01
Recruiting
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07572669Steroid-Refractory Acute Graft-Versus-Host Disease, Acute Graft-Versus-Host Disease, Graft-Versus-Host Disease, Allogeneic Hematopoietic Stem Cell Transplantation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
42
Wuhan
2025-09-01
Not yet open
Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency
NCT07126288Growth Hormone Deficiency in Children, Growth Hormone Deficiency (GHD), Growth Hormone
Shenzhen Kexing Pharmaceutical Co., Ltd.
Phase 2/3
268
Xiamen, Nanyang, Xinxiang, Wuhan, Suzhou, Nanchang, Pingxiang, Changchun
2025-08-31
Not yet open
A Study of IBI363 Combination Therapy in Participants With Advanced Solid Tumors
NCT07124793EGFR Mutant NSCLC and Platinum Resistant Ovarian Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
60
Wuhan
2025-08-31
Not yet open
Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis
NCT07131150Idiopathic Pulmonary Fibrosis (IPF)
Ruijin Hospital
Phase 2
66
Beijing, Guangzhou, Shenzhen, Hebei, Zhengzhou, Wuhan, Changsha, Nanjing
2025-08-31
Recruiting
A Study of SKB518 in Patients With Lung Cancer
NCT07019675Lung Carcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
192
Shenzhen, Nanning, Zhengzhou, Wuhan, Xiangyang, Changsha, Nanchang, Jinan
2025-08-29
Recruiting
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
NCT06841679Gastric or Gastroesophageal Junction Adenocarcinoma
Beijing Biostar Pharmaceuticals Co., Ltd.
Phase 2/3
778
Anyang, Guangzhou, Jinan, Shenyang, Taiyuan, Tianjin, Wuhan, Zhengzhou
2025-08-28
Recruiting
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
NCT07145229Acute Gouty Arthritis, Gout Flare, Gout Flares, Acute Gout Flare
Atom Therapeutics Co., Ltd
Phase 2
380
Beijing, Nanning, Langfang, Wuhan, Xiangtan, Zhuzhou, Huai'an, Pingxiang
2025-08-26
Recruiting
LineMatrixยฎ Biological Vascular Graft for the Creation of Arteriovenous Graft
NCT07773051Arteriovenous Graft
Longhua Hospital
Not applicable
326
Beijing, Chongqing, Shenzhen, Shijiazhuang, Zhengzhou, Wuhan, Nanjing, Nanchang
2025-08-25
Recruiting
Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
NCT07126470Cataract, Retinitis Pigmentosa (RP)
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
88
Guangzhou, Shenzhen, Wuhan
2025-08-25
Recruiting
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
NCT07181473Lung Cancer (NSCLC), Prostate Cancer, Esophageal Cancer, Solid Tumor Malignancies
Phrontline Biopharma
Phase 1
200
Zhengzhou, Wuhan, Hangzhou, Shanghai
2025-08-25
Recruiting
Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease
NCT07077486Lupus or SLE, Interstitial Lung Disease, Systemic Lupus Erythematosus
Tongji Hospital
Phase 4
100
Wuhan
2025-08-25
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NCT06959524Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation
Not applicable
1,616
Beijing, Beijin, Guangzhou, Wuhan, Xi'an
2025-08-21
Recruiting
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
NCT07154706Non-small Cell Lung Cancer (NSCLC)
Nuvation Bio Inc.
Phase 3
180
Beijing, Guangzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Nantong, Nanchang
2025-08-21
Recruiting
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
NCT07150663Non-small Cell Lung Cancer
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3
134
Wuhan
2025-08-20
Recruiting
PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
NCT07133750CRC (Colorectal Cancer)
Biotheus Inc.
Phase 2
100
Beijing, Guangzhou, Harbin, Wuhan, Changchun, Jinan, Shanghai, Chengdu
2025-08-19
Recruiting
Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2
NCT07097818Type 1 Diabetes
Second Xiangya Hospital of Central South University
Not applicable
400
Beijing, Quanzhou, Shenzhen, Tangshan, Luoyang, Wuhan, Changsha, Shenyang
2025-08-18
Recruiting
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
NCT06868485Non Small Cell Lung Cancer
Wayshine Biopharm, Inc.
Phase 2
40
Fuzhou, Wuhan, Shanghai, Tianjin
2025-08-18
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
NCT07086976Autoimmune Haemolytic Anaemia
Sanofi
Phase 3
90
Beijing, Chengde, Guangzhou, Hohhot, Nanchang, Suzhou, Tianjin, Wuhan
2025-08-18
Recruiting
A Clinical Trial of SIBP-A16 Injection in Healthy Adults
NCT07106918Respiratory Syncytial Virus (RSV)
Shanghai Institute Of Biological Products
Phase EARLY_PHASE1
140
Wuhan
2025-08-17
Recruiting
A Study of IL4Rฮฑ Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
NCT07154342Allergic Rhinitis, Seasonal
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Phase 3
150
Wuhan
2025-08-15
Not yet open
A Prospective, Open-label, Exploratory Basket Trial to Evaluate the Efficacy and Safety of Sintilimab Combined With Pyrotinib ยฑ Chemotherapy in Patients With Advanced Digestive System Tumors
NCT07053150Advanced Digestive System Tumor
Tongji Hospital
Phase 2
80
Wuhan
2025-08-15
Recruiting
A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer
NCT07135544Biliary Tract Cancer, Biliary Tract Cancer (CCA)
Yongjun Chen
Phase 2
37
Wuhan
2025-08-14
Recruiting
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
NCT06948318Immune Thrombocytopenic Purpura (ITP)
Takeda
Phase 3
150
Beijing, Guangzhou, Nanning, Shijiazhuang, Wuhan, Zhengzhou, Suzhou, Nanchang
2025-08-14
Recruiting
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
NCT07070232Advanced Solid Tumor
BioNTech SE
Phase 1/2
1,438
Hangzhou, Tianjin, Wuhan
2025-08-12
Recruiting
Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above
NCT07152639Tuberculosis
Chengdu CoenBiotech Co., Ltd
Phase 3
1,784
Beijing, Hunan, Liuzhou, Xinxiang, Wuhan, Yichang, Chengdu
2025-08-09
Active, closed
Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers
NCT07162181Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, B-cell Lymphoma
Eli Lilly and Company
Phase 2
13
Beijing, Guangzhou, Harbin, Shanghai, Tianjin, Wuhan
2025-08-07
Recruiting
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
NCT07007793Primary Hyperaldosteronism
AstraZeneca
Phase 3
250
Beijing, Changsha, Chengdu, Chongqing, Nanjing, Shanghai, Tianjin, Wuhan
2025-08-07
Recruiting
Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation
NCT06871228Atrial Fibrillation (AF)
Beijing Anzhen Hospital
Not applicable
4,100
Hefei, Beijing, Guangzhou, Shijiazhuang, Harbin, Luohe, Zhengzhou, Wuhan
2025-08-05
Recruiting
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
NCT06615596Atrial Fibrillation (AF)
China National Center for Cardiovascular Diseases
Phase EARLY_PHASE1
3,160
Beijing, Guangzhou, Shenzhen, Zhengzhou, Wuhan, Shanghai, Taiyuan, Chengdu
2025-08-05
Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
NCT07062965Breast Cancer
Pfizer
Phase 3
400
Hefei, Fuzhou, Guangzhou, Baoding, Wuhan, Changsha, Nanjing, Dalian
2025-08-05
Recruiting
CAR-T Therapy for Refractory Autoimmune Diseases
NCT07059169Autoimmune Diseases
LiangZou
Not applicable
20
Wuhan
2025-08-04
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
NCT07005102Non-Squamous Non-Small Cell Lung Cancer
AbbVie
Phase 2/3
854
Wuhan
2025-08-03
Recruiting
Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence
NCT06954116Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Tongji Hospital
Phase 2
26
Wuhan
2025-08-01
Recruiting
The Clinical Value of Deep Learning-Based Reconstruction Techniques in Cardiac MRI Scanning
NCT07274436Cardiac Disease
Lian Yang
Observational
50
Wuhan
2025-08-01
Not yet open
Efficacy and Safety of Calculus Bovis Sativus in Adults With MAFLD
NCT07085962Metabolic Dysfunction-associated Fatty Liver Disease
Huazhong University of Science and Technology
Not applicable
40
Wuhan
2025-08-01
Recruiting
Clinical Value of Deep Learning Reconstruction Technology in Ankle MRI
NCT07274423Ankle Trauma
Lian Yang
Observational
120
Wuhan
2025-08-01
Not yet open
CEH-EUS for Differentiating GISTs and Leiomyomas: A Multicenter Prospective Self-Controlled Study
NCT07106411Submucosal Tumor, Gastrointestinal Stromal Tumor (GIST), Leiomyoma
Huazhong University of Science and Technology
Observational
288
Wuhan
2025-08
Recruiting
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
NCT07118813Renal Cell Carcinoma (Kidney Cancer)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
400
Wuhan
2025-08
Recruiting
Effects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted Thoracoscopic Surgery
NCT07028593Myocardial Injury, Thoracic Diseases, Thoracoscopic Surgery
Tongji Hospital
Phase 4
1,058
Wuhan
2025-07-31
Not yet open
A Clinical Study Evaluating the Dermal Safety of Soluble Denosumab Microneedle Patches
NCT07085520Osteoarthritis, Osteoarthritis (OA) of the Knee, Osteoporosis, Osteoporosis (Senile)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1
12
Wuhan
2025-07-31
Recruiting
A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma
NCT07124936Diffuse Large B Cell Lymphoma (DLBCL)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1/2
97
Beijing, Fuzhou, Guangzhou, Nanning, Harbin, Zhengzhou, Wuhan, Changsha
2025-07-30
Recruiting
Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.
NCT07019012T2DM
Huazhong University of Science and Technology
Phase 4
170
Wuhan
2025-07-30
Not yet open
Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study
NCT07064668Hepatocellular Carcinoma
Tongji Hospital
Phase 2
300
Wuhan
2025-07-30
Recruiting
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
NCT06721013Immune Thrombocytopenia (ITP)
Eli Lilly and Company
Phase 1/2
68
Guangzhou, Jinan, Tianjin, Wuhan
2025-07-30
Recruiting
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
NCT06911502Follicular Lymphoma
Celgene
Phase 3
400
Beijing, Fuzhou Fujian, Guangzhou, Harbin, Wuhan, Changsha, Hohhot, Suzhou
2025-07-28
Recruiting
A Study of LY4175408 in Participants With Advanced Cancer
NCT07046923Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Endometrial Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 1
240
Chengdu, Shanghai, Wuhan
2025-07-28
Recruiting
Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis
NCT07078136Submucosal Tumor, Gastrointestinal Stromal Tumor (GIST), Leiomyoma, Schwannoma
Huazhong University of Science and Technology
Observational
130
Wuhan
2025-07-28
Recruiting
Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer ๏ผˆRadiogenomics-Esophagus๏ผ‰
NCT07354295Esophageal Cancer
Shu Peng
Observational
1,500
Wuhan
2025-07-26
Recruiting
Digital Out-of-hospital Management on Clinical Outcomes in Patients With Early Cardiogenic Shock
NCT07085221Shock, Cardiogenic, Shock
Renmin Hospital of Wuhan University
Not applicable
472
Wuhan
2025-07-26
Recruiting
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
NCT07066657Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Pancreatic Cancer
ArriVent BioPharma, Inc.
Phase 1
572
Beijing, Chongqing, Zhejiang, Heilongjiang, Zhengzhou, Wuhan, Changsha, Shandong
2025-07-25
Recruiting
Natural History Study of Inherited Retinal Diseases
NCT07085533Retinal Dystrophies, Color Vision Defects, Vision Disorders, Macular Degeneration
Zhongmou Therapeutics
Observational
200
Wuhan
2025-07-20
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of Tacabrutideg (BGB-16673) in Adults With Chronic Spontaneous Urticaria and in Healthy Participants
NCT07005713Chronic Spontaneous Urticaria
BeOne Medicines
Phase 1
58
Beijing, Chongqing, Guangzhou, Wuhan, Changsha, Qingdao, Chengdu, Hangzhou
2025-07-19
Active, closed
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
NCT06468033Primary Myelofibrosis, Myeloproliferative Neoplasm
PharmaEssentia
Phase 3
160
Beijing, Chongqing, Guangdong, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanjing
2025-07-18
Recruiting
A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.
NCT07052253Hepatocellular Carcinoma (HCC)
Akeso
Phase 2
100
Wuhan
2025-07-18
Recruiting
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
NCT06953089Solid Tumors
DualityBio Inc.
Phase 2
450
Beijing, Dongguan, Henan, Xinxiang, Hubei, Wuhan, Changsha, Xuzhou
2025-07-18
Recruiting
A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors
NCT07043751Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
216
Beijing, Dongguan, Guangdong, Guangzhou, Anyang, Zhengzhou, Wuhan, Changsha
2025-07-15
Recruiting
GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)
NCT07058298Generalized Myasthenia Gravis (gMG)
Daishi Tian
Phase EARLY_PHASE1
6
Wuhan
2025-07-15
Recruiting
Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE
NCT07031713Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1
12
Wuhan
2025-07-11
Recruiting
A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors
NCT06953323Advanced Solid Tumor
Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Phase 1/2
86
Beijing, Fuzhou, Guangzhou, Nanning, Wuhan, Changsha, Shenyang, Hangzhou
2025-07-10
Recruiting
An Gong Niuhuang Wan Promotes the Postoperative Neurological Function Recovery of Patients With Traumatic Brain Injury
NCT07074938Traumatic Brain Injury
Huaqiu Zhang
Not applicable
60
Wuhan
2025-07-10
Not yet open
Phase II Exploratory Study of Sequential Triple Therapy (Temozolomide/Anlotinib/Bemarituzumab) in Combination With Concurrent Radiotherapy With Temozolomide and Anlotinib for the Maintenance Treatment of Diffuse Midline Gliomas in Children
NCT07020052Maintenance Treatment of Diffuse Midline Gliomas in Children
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
33
Wuhan
2025-07-10
Recruiting
MITRIS China Post Market Clinical Follow-up (PMCF) Study
NCT07059793Mitral Valve Replacement
Edwards Lifesciences
Observational
250
Beijing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Nanjing, Xi'an, Jinan
2025-07-08
Recruiting
Interventions for Silent Brain Infarction and Perioperative Neurocognitive Disorders in Cardiovascular Surgery
NCT07048002Silent Brain Infarction, Neurocognitive Disorders, Cardiac Surgery, Neuroprotective
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
912
Beijing, Wuhan
2025-07-06
Recruiting
Clinical Study to Evaluate the Safety and Efficacy of ฮณฮด T Cells for the Prevention of Relapse After Allogeneic Transplantation in Patients With High-risk Acute Myeloid Leukemia
NCT07237230High-Risk Acute Myeloid Leukemia
Donghua Zhang
Not applicable
40
Wuhan
2025-07-01
Not yet open
The Safety, Efficacy, and Cellular Metabolic Kinetics of CT1192 in Treating Patients With Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis
NCT07033299ANCA Associated Vasculitis (AAV)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1
12
Wuhan
2025-07-01
Not yet open
AI-guided TIPS Procedure
NCT06837974Portal Hypertension Related to Cirrhosis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
180
Wuhan
2025-07-01
Recruiting
Rectal NSAIDs With/Without PD Stent for PEP Prevention
NCT07117318Post-ERCP Acute Pancreatitis, Non-steroid Anti-inflammatory Drugs, Pancreatic Duct Stent Placement
Air Force Military Medical University, China
Not applicable
1,278
Beijing, Chongqing, Xiamen, Harbin, Kaifeng, Wuhan, Changsha, Xi'an
2025-07-01
Recruiting
Effect of Full-House ESS With Nasopharyngeal Lymphoid Tissue Ablation on Nasal Polyps
NCT07245329Nasal Polyps
Tongji Hospital
Not applicable
32
Wuhan
2025-07-01
Not yet open
Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors
NCT06994078Urothelial Carcinoma, Breast Cancer, Lung Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
56
Wuhan
2025-07-01
Not yet open
Patient Journey in Advanced Gynecologic Cancers
NCT07015593Genital Neoplasms, Female, Uterine Cervical Neoplasms, Endometrial Carcinoma
Tongji Hospital
Observational
780
Hefei, Guangzhou, Wuhan, Chongqing
2025-07-01
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
NCT06855277Prostate Cancer
Novartis Pharmaceuticals
Phase 3
940
Fuzhou, Guangzhou, Wuhan, Nanjing, Shenyang, Chengdu, Hangzhou, Beijing
2025-07-01
Recruiting
Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD
NCT06885957NMO Spectrum Disorder
Tongji Hospital
Observational
200
Wuhan
2025-07-01
Recruiting
Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)
NCT07059923Lung Cancer (Diagnosis)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
400
Wuhan
2025-07
Not yet open
22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions
NCT07012694Pancreatic Neoplasms, Mediastinal Neoplasms, Abdominal Neoplasm, Excluding Pancreas Neoplasm
Huazhong University of Science and Technology
Not applicable
576
Wuhan
2025-07
Recruiting
Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)
NCT07059936Hepatocellular Carcinoma (HCC)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
350
Wuhan
2025-07
Recruiting
Cohort Study of Intrauterine Diseases
NCT07048327Endometrial Cancer, Endometrial Hyperplasia, Endometrial Polyps
Wenwen Wang
Observational
2,000
Wuhan
2025-07
Not yet open
Surgery for Relapsed Ovarian Cancer in Precision
NCT06602063Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group
Phase 1/2
33
Shanghai, Wuhan
2025-07
Recruiting
Dalpiciclib Combined With Aromatase Inhibitors and Olmesartan as the First-line Treatment for HR+/HER2- Advanced Breast Cancer
NCT07810088HR+ / HER2- Advanced Breast Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
40
Wuhan
2025-06-28
Recruiting
Randomised Controlled Trial of Artificial Intelligence-assisted Health Education
NCT07305337Leukaemia, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Lymphoma
Zhongnan Hospital
Not applicable
196
Wuhan
2025-06-28
Active, closed
A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD
NCT06843408Chronic Graft-versus-host-disease
Incyte Corporation
Phase 1/2
32
Beijing, Chengdu, Chongoing, Guangzhou, Hangzhou, Shanghai, Tianjin, Wuhan
2025-06-25
Recruiting
An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis
NCT06946199Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1
28
Wuhan
2025-06-23
Recruiting
A Study in Children With Achondroplasia
NCT07301463Achondroplasia
Abbisko Therapeutics Co, Ltd
Observational
260
Beijing, Guangzhou, Zhengzhou, Wuhan, Shanghai, Chengdu, Hangzhou
2025-06-20
Recruiting
Neoadjuvant Low-Dose Radiotherapy Combined With Adebrelimab and Single-Agent Albumin-Bound Paclitaxel Chemotherapy for Early-Stage Oral Squamous Cell Carcinoma: A Prospective, Single-Arm Clinical Trial
NCT07007364Early-Stage Oral Squamous Cell Carcinoma
Jun Jia
Phase 2
30
Wuhan
2025-06-19
Rows per page Showing 401–500 of 1343
Previous 3 4 5 6 7 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/wuhan?page=5

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,343 of those studies with a site in Wuhan.

How many clinical trials are recruiting in Wuhan?

798 of the 1,343 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 226 have not yet opened recruitment, 281 are active but closed to new participants, and 38 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.